CombsCA, GoffmanD, PettkerCM, Patient Safety and Quality Committee. Society for maternal–fetal medicine special statement: A critique of postpartum readmission rate as a quality metric. Am J Obstet Gynecol, 2022; 226(4):B2–B9; doi: 10.1016/j.ajog.2021.11.1355
2.
ClappMA, LittleSE, ZhengJ, et al.Hospital-level variation in postpartum readmissions. JAMA, 2017; 317(20):2128–2129; doi: 10.1001/jama.2017.2830
3.
JeganathanS, SolmonovichR, AlvarezA, et al.Socioeconomic, demographic, and clinical factors associated with postpartum readmission. J Womens Health, 2025; 34(3):346–353; doi: 10.1089/jwh.2024.0040
4.
PetersenEE, DavisNL, GoodmanD, et al.Vital signs: Pregnancy-related deaths, United States, 2011-2015, and strategies for prevention, 13 States, 2013-2017. MMWR Morb Mortal Wkly Rep, 2019; 68(18):423–429; doi: 10.15585/mmwr.mm6818e1
5.
MacDormanMF, ThomaM, DeclcerqE, et al.Racial and ethnic disparities in maternal mortality in the United States using enhanced vital records, 2016–2017. Am J Public Health, 2021; 111(9):1673–1681; doi: 10.2105/AJPH.2021.306375
6.
ChornockR, IqbalSN, KawakitaT. Racial disparity in postpartum readmission due to hypertension among women with pregnancy-associated hypertension. Am J Perinatol, 2021; 38(12):1297–1302; doi: 10.1055/s-0040-1712530
7.
SmithsonSD, GreeneNH, EsakoffTF. Risk factors for re-presentation for postpartum hypertension in patients without a history of hypertension or preeclampsia. Am J Obstet Gynecol MFM, 2021; 3(2):100297.
8.
BarryMJ, NicholsonWK, SilversteinM, et al.US Preventive Services Task Force. Screening for hypertensive disorders of pregnancy: US preventive services task force final recommendation statement. JAMA, 2023; 330(11):1074–1082; doi: 10.1001/jama.2023.16991
9.
HendersonJT, WebberEM, VescoKK, et al.U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Screening for Hypertensive Disorders of Pregnancy: An Evidence Update for the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2023. Sep. Report No.: 22-05299-EF-1.
Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol, 2013; 122:1122–1131; doi: 10.1097/01.AOG.0000437382.03963.88
12.
GibsonKS, HameedAB, Patient Safety and Quality Committee, Society for Maternal-Fetal Medicine.. Society for Maternal-Fetal Medicine Special Statement: Checklist for postpartum discharge of women with hypertensive disorders. Am J Obstet Gynecol, 2020; 223(4):B18–B21; doi: 10.1016/j.ajog.2020.07.009
13.
GibsonKS, CombsCA, BauerS, et al.Patient Safety and Quality Committee. Society for Maternal-Fetal Medicine Special Statement: Quality metric for timely postpartum follow-up after severe hypertension. Am J Obstet Gynecol, 2022; 227(3):B2–B8; doi: 10.1016/j.ajog.2022.05.045
